![](/img/cover-not-exists.png)
Efficacy and Safety of a Second Adalimumab Treatment Cycle in Psoriasis Patients who Relapsed after Adalimumab Discontinuation or Dosage Reduction: A Double-Blind, Randomized, Placebo-Controlled Trial
Larian, Amir, Emer, Jason J., Gordon, Kenneth, Blum, Robin, Okun, Martin, Gu, Yihua, Lebwohl, MarkVolume:
17a
Language:
english
Journal:
Psoriasis Forum
DOI:
10.1177/247553031117a00201
Date:
June, 2011
File:
PDF, 317 KB
english, 2011